He started out by forming one of the earliest dot com businesses, and went on to form many other internet based companies. Now entrepreneur Eric Lefkofsky has branched out into the medical field. He has co-founded the company Tempus.
Formed in 2016, Lefkofsky’s newest venture helps doctors deliver a more personalized form of care to cancer patients. This is made possible by Tempus creating a huge library of molecular and clinical data, as well as a system to make this data more easily accessible. Some of the services Tempus.com provides doctors with are genomic sequencing and analysis of molecular and therapeutic data. One of the goals is for patients to benefit from treatment done to past patients with similar ailments. The analysis of the data can also aid doctors and researchers in finding new cancer treatments and to help with cancer gene discovery. Read more on http://www.chicagotribune.com/classified/realestate/elitestreet/ct-elite-street-glencoe-groupon-lefkofsky-1211-biz-20161206-story.html
Before getting involved in cancer research, the Detroit-born Eric Lefkofsky graduated from the University of Michigan Law School, and worked as a carpet salesman while attending school. Just a few years after graduation, Lefkofsky and his friend, Brad Keywell, created the internet company Starbelly, which sold promotional products. From there, Lefkofsky embarked on a path that saw him found numerous companies. These include InnerWorkings, a print procurement service, Echo Global Logistics, a freight logistics company, and Lightbank, which helped form new businesses in Chicago. Lefkofsky also served as CEO of the e-commerce company Groupon. Refer to www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html.
Lefkofsky has given back through his charitable and community work. He and his wife formed the Lefkofsky Foundation, a charitable trust that supports scientific and educational organizations around the world. He also sits on the board of directors for Chicago’s Children’s Memorial Hospital. Lefkofsky’s interests extend beyond the tech and medical worlds, as he is on the board of directors for the Art Institute of Chicago and is a trustee for the Steppenwolf Theatre Company.
Follow him at linkedin.com